← FDA Drug Approvals (Drugs@FDA)

DIFFERIN

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2007-06-19

Drug application

FDA Application #

NDA021753

Application type

New Drug Application

Brand name

DIFFERIN

Generic name

ADAPALENE

Active ingredients

ADAPALENE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

GALDERMA LABS LP

Manufacturer

Mayne Pharma Commercial LLC.

First approval

2007-06-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown